rs148999619

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006267.5(RANBP2):​c.2559T>A​(p.Asp853Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,611,274 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 48 hom., cov: 27)
Exomes 𝑓: 0.0012 ( 37 hom. )

Consequence

RANBP2
NM_006267.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.531

Publications

1 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040726364).
BP6
Variant 2-108758505-T-A is Benign according to our data. Variant chr2-108758505-T-A is described in ClinVar as Benign. ClinVar VariationId is 381436.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0125 (1890/151616) while in subpopulation AFR AF = 0.0444 (1828/41132). AF 95% confidence interval is 0.0427. There are 48 homozygotes in GnomAd4. There are 857 alleles in the male GnomAd4 subpopulation. Median coverage is 27. This position passed quality control check.
BS2
High AC in GnomAd4 at 1890 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.2559T>A p.Asp853Glu missense_variant Exon 18 of 29 ENST00000283195.11 NP_006258.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.2559T>A p.Asp853Glu missense_variant Exon 18 of 29 1 NM_006267.5 ENSP00000283195.6
RANBP2ENST00000697737.1 linkc.2559T>A p.Asp853Glu missense_variant Exon 18 of 27 ENSP00000513426.1
RANBP2ENST00000697740.1 linkc.2481T>A p.Asp827Glu missense_variant Exon 18 of 27 ENSP00000513427.1

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1887
AN:
151502
Hom.:
48
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0445
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00269
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000736
Gnomad OTH
AF:
0.00769
GnomAD2 exomes
AF:
0.00309
AC:
776
AN:
250920
AF XY:
0.00223
show subpopulations
Gnomad AFR exome
AF:
0.0455
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000706
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.00119
AC:
1732
AN:
1459658
Hom.:
37
Cov.:
35
AF XY:
0.00103
AC XY:
749
AN XY:
726146
show subpopulations
African (AFR)
AF:
0.0450
AC:
1501
AN:
33372
American (AMR)
AF:
0.00130
AC:
58
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86164
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000484
AC:
2
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000333
AC:
37
AN:
1111828
Other (OTH)
AF:
0.00218
AC:
131
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
81
161
242
322
403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0125
AC:
1890
AN:
151616
Hom.:
48
Cov.:
27
AF XY:
0.0116
AC XY:
857
AN XY:
74096
show subpopulations
African (AFR)
AF:
0.0444
AC:
1828
AN:
41132
American (AMR)
AF:
0.00269
AC:
41
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4766
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000736
AC:
5
AN:
67942
Other (OTH)
AF:
0.00761
AC:
16
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
77
155
232
310
387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00649
Hom.:
3
Bravo
AF:
0.0143
ESP6500AA
AF:
0.0377
AC:
166
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00390
AC:
474

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Familial acute necrotizing encephalopathy Benign:1
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.38
T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.34
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.7
L
PhyloP100
0.53
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.028
Sift
Benign
0.12
T
Sift4G
Benign
0.45
T
Polyphen
0.023
B
Vest4
0.15
MutPred
0.15
Gain of catalytic residue at D853 (P = 0.1918);
MVP
0.27
MPC
1.0
ClinPred
0.0039
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.046
gMVP
0.24
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148999619; hg19: chr2-109374961; API